For First Time MEDMEME, LLC. Strategic Planning Competitive Intelligence is Available in New Series of Syndicated Reports Focusing on Ten Top Therapeutic Categories

Share Article

To facilitate biopharma company planning, information from MedMeme’s database documents four views of how market demand is created and how that demand helps shape, in the ten major therapeutic categories, the competitive strategies firms use in the marketplace.

MedMeme LLC., a global leader in providing comprehensive database platforms detailing medical and scientific information, announces the launch of syndicated, therapeutic-category-focused reports that provide insight into how medical information is captured and communicated in order to Create Demand and shape biopharma markets, providing guidance critically necessary for strategic planning, meeting planning, publication planning, and more.

“MedMeme syndicated reports, 40 in all, provide important analyses of medical and scientific information. They identify the key opinion leader physicians, institutions, and events that produced this information. And they are the sources that create market demand in the world of medicine. These sources are the focus of the MedMeme database. The new MedMeme syndicated reports parse the data to look at the factors that are shaping medical opinions and health care markets right now. They’re ideally suited for professionals in the biotechnology and pharmaceutical industries because the information they contain is comprehensive, accurate, and immediately actionable. Subscribers can quickly assess current major trends, dominant players, rising stars, recent events and developments, and which are the critical factors necessary for success in any given therapeutic category,” says Mahesh Naithani, CEO at MedMeme.

A series of four reports based on MedMeme’s in-depth data make up the initial offering for each of ten therapeutic categories. Each report will provide a current view of a therapeutic category from a particular perspective:

  •     TrendsMemeTM Reports – These reports cover key indications, companies, and drugs to reveal dominant player positioning as well as relevant issues and developments in treatment and the marketplace. They explain the status of a therapeutic category and the major trends that are driving change and influencing R&D success.
  •     IntellMemeTM Reports – Reports that identify the disease areas and drugs that receive the most attention—that is, the largest share-of-voice—from peer-reviewed medical journals, societies, meetings and congresses, and key opinion leaders. They illustrate trends over time and highlight strategic options.
  •     C-O-E/MemeTM Reports – These reports pinpoint the top 50 medical centers-of-excellence by specific therapeutic categories, giving guidance for selection of partners to conduct clinical research, recruit KOLs for specific disease expertise and affiliations, provide educational initiatives, and more. The reports are a direct derivative of MedMeme’s on-line, continuously updated, searchable database product platform C-O-E/MemeTM.
  •     TrialMemeTM Reports – The reports identify, by location, leading clinical trial sites worldwide, including principal and site investigators, trial status, entity conducting the trial, drug, and where the results have been presented. This knowledge can help reduce both trial timelines and costs of future trials by providing historic perspective to sponsors and CROs. The reports are a direct derivative of MedMeme’s on-line, continuously updated, searchable database product platform TrialMemeTM.

These syndicated reports can be purchased separately, based on therapeutic category of interest, or by series at discounted pricing. To learn more about the reports, see http://www.medmeme.com/reports.

About MedMeme Syndicated Reports:

MedMeme reports slice the data by therapeutic categories from more than 60,000 URLs yielding 50 million data points, the professional bodies of work of over 1.5 million key opinion leaders, more than 6.3 million medical conference presentations, over 600,000 clinical trials in 50 countries, and information from governments, societies, and institutions to map, measure, and project the pathways of future market movement. MedMeme’s data-intensive reports compile and analyze trends over time to show the top conferences, the top journals, the top contributors, the top institutions, and more, to illustrate—using easily navigated text and extensive tables and graphs—the most successful approaches to creating awareness, interest, and demand in any therapeutic category.

For more information, contact:

MedMeme, LLC                     
Yan Barshay, Executive Vice President
+1 212-725-5992    
yan(at)medmeme(dot)com    

Ray Wright, Vice President, Sales
+ 1 508-278-4595
rwright(at)medmeme(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Yan Barshay

Raymond Wright
MedMeme LLC
1-508-278-4595
Email >
Visit website